BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10217600)

  • 21. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
    Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
    Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
    Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
    Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
    Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A recombinant human adenovirus vaccine against rabies.
    Prevec L; Campbell JB; Christie BS; Belbeck L; Graham FL
    J Infect Dis; 1990 Jan; 161(1):27-30. PubMed ID: 2295855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
    Wright PF; Mestecky J; McElrath MJ; Keefer MC; Gorse GJ; Goepfert PA; Moldoveanu Z; Schwartz D; Spearman PW; El Habib R; Spring MD; Zhu Y; Smith C; Flores J; Weinhold KJ;
    J Infect Dis; 2004 Apr; 189(7):1221-31. PubMed ID: 15031791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of an E1-deleted, replication-defective adenovirus recombinant expressing the rabies virus glycoprotein for early vaccination of mice against rabies virus.
    Wang Y; Xiang Z; Pasquini S; Ertl HC
    J Virol; 1997 May; 71(5):3677-83. PubMed ID: 9094641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.
    Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA
    Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.
    Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH
    Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.
    Xiang ZQ; Spitalnik S; Tran M; Wunner WH; Cheng J; Ertl HC
    Virology; 1994 Feb; 199(1):132-40. PubMed ID: 8116236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucosally delivered E1-deleted adenoviral vaccine carriers induce transgene product-specific antibody responses in neonatal mice.
    Xiang Z; Li Y; Gao G; Wilson JM; Ertl HC
    J Immunol; 2003 Oct; 171(8):4287-93. PubMed ID: 14530353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A thermostable messenger RNA based vaccine against rabies.
    Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immune response of mice to replication-defective recombinant adenovirus containing glycoprotein gene of rabies virus 3aG strain].
    Li W; Zhang Y; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):61-5. PubMed ID: 12526306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
    Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
    Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological and immunogenic properties of rabies virus glycoprotein expressed by canine herpesvirus vector.
    Xuan X; Tuchiya K; Sato I; Nishikawa Y; Onoderaz Y; Takashima Y; Yamamoto A; Katsumata A; Iwata A; Ueda S; Mikami T; Otsuka H
    Vaccine; 1998; 16(9-10):969-76. PubMed ID: 9682345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
    Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
    J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of glycoprotein gene of the rabies virus 3aG strain by E-3 deleted adenovirus recombinant.
    Zhang X; Zhang Y; Li W
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):281-4. PubMed ID: 11498699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein.
    Fu ZF; Rupprecht CE; Dietzschold B; Saikumar P; Niu HS; Babka I; Wunner WH; Koprowski H
    Vaccine; 1993; 11(9):925-8. PubMed ID: 8212838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies.
    Borhani K; Ajorloo M; Bamdad T; Mozhgani SH; Ghaderi M; Gholami AR
    Arch Iran Med; 2015 Apr; 18(4):223-7. PubMed ID: 25841942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.